Skip to main content

Ex-Genentech CEO's anti-aging drug company starts first clinical trial

The first drug in a clinical trial from Calico's billion-dollar collaboration with AbbVie is a capsule focused on cancer immunotherapy.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.